Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022

    NEXT STORY
    Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
    PREV STORY
    Enhancing Primary Care Delivery to be More Equitable for All
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech

    PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech ...

    author_avatar
    NASDAQ Market News

    ContraFect to Present at 10th Annual Biotech Showcase

    YONKERS, N.Y., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    22 Winners Receive the 2018 MAP Award for High Performance in Revenue Cycle

    Westchester, Illinois, May 21, 2018 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) ...

    author_avatar
    NASDAQ Market News